Pharmaceutical anti-counterfeiting technologies: market analysis 2011-2021
Publication date: 11/04/11
Number of pages: 119
Pricing:
- Single user license: £1,499
- Departmental (5 users): £2,999
- Company wide: £4,999
- Global site: £6,999
Report Details
What are the commercial prospects for pharmaceutical anti-counterfeiting technology? This new report outlines the industry and market's revenue potential from 2011 to 2021 and shows you revenue prospects for pharma anti-counterfeiting technologies at total world, submarket and national levels to 2021. The anti-counterfeiting activities of companies such as Pfizer, J&J, GSK, Sanofi-Aventis, Novartis and AstraZeneca are discussed.
The activities and potential of anti-counterfeiting specialists, such as NanoGuardian, Ahura Scientific, TruTag Technologies, Colorcon, Authentix, 3M, Cortegra and Covectra are also covered. The study forecasts revenues for radio frequency identification (RFID), pharmaceutical taggant, hologram/OVD, security ink and watermark technologies to 2021. You will see their market potentials.
Which pharma anti-counterfeiting technologies and national markets will provide the best opportunities from 2011 to 2021? What effects will governmental policies have? This report gives answers you need and provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. Revenue forecasts, growth rates and market shares are also provided as well as a SWOT/STEP analysis, review of companies and product developments, and opinions from a survey.
67 tables and charts and three research interviews are included, this report helping you to understand pharma anti-counterfeiting activities this decade. Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021 describes revenue trends, opportunities and challenges, and provides the following advantages:
- You will receive hard data for the pharmaceutical anti-counterfeiting industry and market from 2010 to 2021
- You will discover revenue forecasting for the overall world market to 2021
- You will see revenue predictions for leading technologies - RFID, taggants, holograms/OVDs, security inks and watermarks - to 2021
- You will assess anti-counterfeiting needs at world and regional level
- You will find revenue predictions for leading geographical markets to 2021 (US, UK, Germany, France, Japan, Italy, Canada, Spain, China and India)
- You will assess the implications of government mandates for product serialisation, seeing how these will affect the activities of pharma companies
- You will assess leading companies in pharma anti-counterfeiting, discovering their activities, potential and commercial outlooks for the future
- You will examine research and development, as well as up-and-coming technologies for tackling drug counterfeiting
- You will investigate competition and opportunities that will influence revenues
- You will see what will stimulate and restrain the industry and market
- You will analyse opportunities for established companies and those seeking to enter the anti-counterfeiting technologies market
- You will view opinion from our survey, including full interview transcripts.
That mix of quantitative and qualitative market analysis sets this report apart, the analysis contained within helping you to stay ahead in commercial knowledge and generally benefitting everybody interested in pharmaceutical anti-counterfeiting technologies.